ADDEX THERAPEUTICS LTD

Analyst Reco. Addex Therapeutics Ltd Nasdaq

Equities

ADXN

US00654J2069

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-27 pm EDT			5-day change	1st Jan Change
8.165 ^USD	+2.32%		-1.51%	+34.96%

Jun. 06	Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024
Jun. 06	Addex Therapeutics' Q1 Net Loss Widens; Revenue Down	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Addex to Present at BioEURquity Europe 2024	May. 08	DJ
HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy	22-06-23	MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate	22-06-17	CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating	22-05-31	MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating	22-02-11	MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target	21-04-21	MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM	18-02-02	GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics	16-06-08	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer